IL51314A - Disodium cromoglycate of low moisture content and pharmaceutical compositions containing it - Google Patents

Disodium cromoglycate of low moisture content and pharmaceutical compositions containing it

Info

Publication number
IL51314A
IL51314A IL51314A IL5131477A IL51314A IL 51314 A IL51314 A IL 51314A IL 51314 A IL51314 A IL 51314A IL 5131477 A IL5131477 A IL 5131477A IL 51314 A IL51314 A IL 51314A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
moisture content
compositions containing
low moisture
disodium cromoglycate
Prior art date
Application number
IL51314A
Other languages
English (en)
Other versions
IL51314A0 (en
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26238506&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL51314(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB3672/76A external-priority patent/GB1562901A/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of IL51314A0 publication Critical patent/IL51314A0/xx
Publication of IL51314A publication Critical patent/IL51314A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL51314A 1976-01-30 1977-01-24 Disodium cromoglycate of low moisture content and pharmaceutical compositions containing it IL51314A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3672/76A GB1562901A (en) 1976-01-30 1976-01-30 Disodium cromoglycate
GB5113676 1976-12-08

Publications (2)

Publication Number Publication Date
IL51314A0 IL51314A0 (en) 1977-03-31
IL51314A true IL51314A (en) 1980-03-31

Family

ID=26238506

Family Applications (1)

Application Number Title Priority Date Filing Date
IL51314A IL51314A (en) 1976-01-30 1977-01-24 Disodium cromoglycate of low moisture content and pharmaceutical compositions containing it

Country Status (14)

Country Link
JP (1) JPS5294411A (es)
AU (1) AU512593B2 (es)
DE (1) DE2703119A1 (es)
DK (2) DK154766C (es)
ES (1) ES455478A1 (es)
FI (1) FI770215A (es)
FR (1) FR2339604A1 (es)
IE (1) IE44760B1 (es)
IL (1) IL51314A (es)
LU (1) LU76661A1 (es)
NL (1) NL185446C (es)
NO (2) NO151860C (es)
NZ (1) NZ183157A (es)
SE (2) SE442268B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU522792B2 (en) * 1977-07-19 1982-06-24 Fisons Plc Pressure pack formulation
GB2077100B (en) * 1980-04-30 1985-04-24 Fisons Ltd Pharmaceutical compositions containing cromoglycates
ZA812811B (en) * 1980-04-30 1982-06-30 Fisons Ltd Mixtures and salts of beta-2 selective bronchodilators with cromoglycic acid and salts thereof
JPS63138228U (es) * 1987-03-05 1988-09-12
JPS63138229U (es) * 1987-03-05 1988-09-12
GB8819490D0 (en) * 1988-08-16 1988-09-21 Fisons Plc Pharmaceutical devices
DE68915203T2 (de) * 1988-03-22 1994-09-22 Fisons Plc, Ipswich, Suffolk Pharmazeutische Mischungen.
GB8829478D0 (en) * 1988-12-16 1989-02-01 Harris Pharma Ltd Formulations
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
AU663906B2 (en) * 1991-12-12 1995-10-26 Glaxo Group Limited Medicaments
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
ATE171865T1 (de) * 1991-12-12 1998-10-15 Glaxo Group Ltd Arzneimittel
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
DE69218455T2 (de) 1991-12-18 1997-10-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzusammensetzungen für arzneimittelsuspensionen
WO2000006121A1 (de) 1998-07-24 2000-02-10 Jago Research Ag Medizinische aerosolformulierungen
WO2000007567A1 (de) 1998-08-04 2000-02-17 Jago Research Ag Medizinische aerosolformulierungen
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
ES2691033T3 (es) 2007-02-11 2018-11-23 Map Pharmaceuticals Inc. Método de administración terapéutica de DHE para activar el alivio rápido de la migraña a la vez que se reduce al mínimo el perfil de los efectos secundarios

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (es) * 1956-03-21 1900-01-01
BE556587A (es) * 1957-01-31 1957-04-11
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
US3282791A (en) * 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
IL44022A0 (en) * 1973-01-23 1974-05-16 Fisons Ltd Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NZ183157A (en) 1979-08-31
DE2703119C2 (es) 1990-10-25
JPS5294411A (en) 1977-08-09
NO151860B (no) 1985-03-11
SE442268B (sv) 1985-12-16
DK357588D0 (da) 1988-06-29
DK38077A (da) 1977-07-31
IL51314A0 (en) 1977-03-31
NO780183L (no) 1977-08-02
LU76661A1 (es) 1977-08-03
IE44760L (en) 1977-07-30
FR2339604B1 (es) 1980-12-05
DK156876B (da) 1989-10-16
DK357588A (da) 1988-06-29
SE7700888L (sv) 1977-07-31
FR2339604A1 (fr) 1977-08-26
SE8107278L (sv) 1981-12-04
DK154766B (da) 1988-12-19
JPS6129929B2 (es) 1986-07-10
IE44760B1 (en) 1982-03-24
DK154766C (da) 1989-05-22
NL185446B (nl) 1989-11-16
SE442267B (sv) 1985-12-16
FI770215A (es) 1977-07-31
AU2162677A (en) 1978-08-03
NO770286L (no) 1977-08-02
NL7700911A (nl) 1977-08-02
NL185446C (nl) 1990-04-17
NO151860C (no) 1985-06-19
DK156876C (da) 1990-03-12
DE2703119A1 (de) 1977-08-04
AU512593B2 (en) 1980-10-16
ES455478A1 (es) 1978-02-01

Similar Documents

Publication Publication Date Title
IL51314A (en) Disodium cromoglycate of low moisture content and pharmaceutical compositions containing it
ZA771998B (en) Triazolo-pyrimidines and pharmaceutical compositions containing them
IL51660A0 (en) Hentriakontapeptides their preparation and pharmaceutical compositions containing them
GB1524578A (en) Aminobenzoamide compounds and pharmaceutical compositions containing them
NZ185356A (en) 1-aryloxy-2-hydroxy-3-alkyleneaminopropanes and pharmaceutical compositions containing them
JPS532471A (en) Production of antiibacterial compound and pharmaceutical composition containing same
IL56407A (en) 4-amino-3-sulfamoylpyridyl derivatives and pharmaceutical compositions containing them
IL51301A0 (en) Novel oxygenated n-aryl-diazacyclic compounds their manufacture and pharmaceutical compositions containing them
PT66637A (en) Process for the preparation of 4-trifluoromethylbenzoic acid derivatives and pharmaceutical compositions containing same
IL51339A0 (en) New beta-lactam containing compounds their preparation and pharmaceutical compositions containing them
IL52433A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine and pharmaceutical compositions containing them
IL57268A0 (en) Di-o-n-alkyl clycerol derivatives and pharmaceutical compositions containing them
IL58415A0 (en) Phenyl-quinolizidines their manufacture and pharmaceutical compositions containing them
IL53078A0 (en) New aryl sulphur compounds their preparation and pharmaceutical compositions containing them
IL52409A (en) 5-m-tolyloxyuracil and pharmaceutical compositions containing it
NZ184408A (en) 16-s-acyl derivatives of 16-deacetoxy-fusidic acid and pharmaceutical compositions
IL51572A0 (en) New substituted purines and pharmaceutical compositions containing them
JPS5657785A (en) Chromanol derivative* its manufacture and medicinal composition containing it
IL57476A0 (en) Compounds of the muramy-peptide type and pharmaceutical compositions containing them
JPS5657786A (en) Chromanol derivative* its manufacture and medicinal composition containing it
NZ185267A (en) Derivatives of 1-amino-2hydroxy-3-heterocycloxy-propanes, and pharmaceutical compositions containing them
IL57882A (en) 2-thiophenecarboxamido-alkyl-mercaptans and pharmaceutical compositions containing them
IL52961A0 (en) Pharmaceutical composition containing disodium cromoglycate and its preparation
NZ185318A (en) Derivatives of 1-phenoxy-3-amino-2-propanol and pharmaceutical compositions
PH22810A (en) Phenantrene derivatives and pharmaceutical compositions containing them